Treace Medical Concepts, Inc.
NASDAQ:TMCI
7.94 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Omzet
| 209.357 | 187.118 | 141.838 | 94.419 | 57.365 | 39.416 |
| Kosten van de omzet
| 41.093 | 35.181 | 27.523 | 17.826 | 12.47 | 7.631 |
| Brutowinst
| 168.264 | 151.937 | 114.315 | 76.593 | 44.895 | 31.785 |
| Brutowinstmarge
| 0.804 | 0.812 | 0.806 | 0.811 | 0.783 | 0.806 |
| Onderzoek- en ontwikkelingskosten
| 20.589 | 15.44 | 13.584 | 10.204 | 5.847 | 5.07 |
| Algemene en administratieve kosten
| 55.72 | 47.031 | 32.999 | 18.432 | 6.539 | 4.464 |
| Verkoop- en marketingkosten
| 147.643 | 140.894 | 102.576 | 64.467 | 31.654 | 25.786 |
| Verkoop-, algemene en administratieve kosten
| 203.363 | 187.925 | 135.575 | 82.899 | 38.193 | 30.25 |
| Overige kosten
| 0 | 0 | -0.403 | 0.001 | 0 | 0 |
| Bedrijfskosten
| 223.952 | 203.365 | 149.159 | 93.103 | 44.04 | 35.32 |
| Bedrijfsresultaat
| -55.688 | -51.428 | -34.844 | -16.51 | -0.891 | -3.535 |
| Bedrijfsresultaat ratio
| -0.266 | -0.275 | -0.246 | -0.175 | -0.016 | -0.09 |
| Totaal overige inkomsten en kosten netto
| -0.055 | 1.901 | -7.971 | -4.042 | -4.523 | -0.73 |
| Inkomen voor belasting
| -55.743 | -49.527 | -42.815 | -20.552 | -3.668 | -4.265 |
| Inkomen voor belasting ratio
| -0.266 | -0.265 | -0.302 | -0.218 | -0.064 | -0.108 |
| Belastingkosten
| 0 | 0 | 4.483 | 4.06 | 2.777 | 0.841 |
| Nettowinst
| -55.743 | -49.527 | -47.298 | -24.612 | -6.445 | -5.106 |
| Nettowinstmarge
| -0.266 | -0.265 | -0.333 | -0.261 | -0.112 | -0.13 |
| WPA (Winst Per Aandeel)
| -0.9 | -0.81 | -0.86 | -0.45 | -0.13 | -0.1 |
| Verwaterde WPA
| -0.9 | -0.81 | -0.86 | -0.45 | -0.13 | -0.1 |
| EBITDA
| -42.068 | -39.008 | -34.844 | -15.807 | 2.065 | -2.631 |
| EBITDA ratio
| -0.201 | -0.208 | -0.224 | -0.167 | 0.006 | -0.067 |